CompletedNCT04500301
Pharmacogenomic Testing to Personalize Supportive Oncology
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesDepressionOtherOver 18 Years
Study directory
Back to overviewMental health studies with practical context.
Compare studies and check their requirements with the research team.
CompletedNCT03674138
Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesDepression, AnxietyBehavioralOver 18 Years
CompletedNCT03818191
Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesAddictionDrugA study involving a medication or substance.From 18 Years to 85 Years
TerminatedNCT03730870
Pharmacogenomics for Improving Pediatric ADHD Treatment
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesADHDDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 6 Years to 18 Years
CompletedNCT00516932
Pharmacogenomics of Antidepressant Response in Children and Adolescents
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesSuicidality, OCD, ...ObservationalA study where researchers collect information without assigning a treatment.From 7 Years to 17 Years
CompletedNCT01272531
Pharmacogenomics of Mood Stabilizer Response in Bipolarity (PGBD)
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesBipolarityDrugOver 18 Years
TerminatedNCT03886753
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesPTSDObservationalOver 2 Years
CompletedNCT00914862
Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesADHDDrugFrom 6 Years to 50 Years
CompletedNCT02055287
Pharmacokinetic and Safety Study of LY03004 in Stable people with Schizophrenia or Schizoaffective Disorder
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
CompletedNCT03006367
Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesADHDDrugFrom 6 Years to 17 Years
TerminatedNCT04468360
Pharmacokinetic Study for IV Allopregnanolone
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesPTSDDrugFrom 18 Years to 55 Years
CompletedNCT02578030
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesADHDDrugFrom 6 Years to 17 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.